HR Low-Positive/HER2-Negative Breast Neoplasms trials recruiting in Maryland

Fewer than 3 recruiting trials found.

All HR Low-Positive/HER2-Negative Breast Neoplasms trials nationally

Cities in Maryland

Recruiting trials in Maryland

• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
  NCT06966700 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore